A common blood pressure drug may help a major class of cancer therapies work far better than expected. A widely prescribed blood pressure drug may have an unexpected second life as a cancer therapy ...

Common medications used to treat anemia may also slow down cancer cell growth, according to new research from Finland.

The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.

Common medications used to treat anemia may also slow down cancer cell growth, according to new research from Finland. Researchers from the University of Oulu and the University of Eastern Finland ...

A drug widely used to treat asthma and allergies may also help fight aggressive cancers, reports a new Northwestern Medicine ...

The U.S. Food and Drug Administration on Friday approved an Amgen Inc drug for non-small cell lung cancer with a specific mutation in a gene known as KRAS in patients whose disease has worsened after ...

Good news for a grave concern. Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a new standard of care and improved survival ...

Upfront treatment options set to expand for NSCLC patients with EGFR exon 20 inse ...

In clinical trials, the drug was shown to almost double the survival time for pancreatic cancer patients. Here's how it works and who can get it.